{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:11Z","timestamp":1787020151038,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03790-6","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:49:13Z","timestamp":1744717753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Frequency of insulin resistance among non-diabetic patients with non-alcoholic fatty liver disease using HOMA-IR: an experience of a tertiary care hospital in Karachi, Pakistan"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2651-5179","authenticated-orcid":false,"given":"Lubna","family":"Kamani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moneeba","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeel","family":"Rahat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"3790_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73\u201384. https:\/\/doi.org\/10.1002\/hep.28431.","journal-title":"Hepatology"},{"issue":"4","key":"3790_CR2","first-page":"381","volume":"32","author":"M \u00c7elik","year":"2021","unstructured":"\u00c7elik M, Ahbab S, Hoca E, Ataoglu HE. The assessment of insulin resistance and triglyceride\/glucose index in nonalcoholic fatty liver disease. South Clin Ist Euras. 2021;32(4):381\u201387.","journal-title":"South Clin Ist Euras"},{"key":"3790_CR3","doi-asserted-by":"publisher","first-page":"9330","DOI":"10.3748\/wjg.v20.i28.9330","volume":"20","author":"S Mili\u0107","year":"2014","unstructured":"Mili\u0107 S, Luli\u0107 D, \u0160timac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol. 2014;20:9330\u20137.","journal-title":"World J Gastroenterol"},{"key":"3790_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3790_CR5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","volume":"4","author":"J Li","year":"2019","unstructured":"Li J, Zou B, Yeo YH. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4:389\u201398.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3790_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S2468-1253(19)30093-7","volume":"4","author":"MA De Roza","year":"2019","unstructured":"De Roza MA, Goh GB. The increasing clinical burden of NAFLD in Asia. Lancet Gastroenterol Hepatol. 2019;4:333\u20134.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3790_CR7","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","author":"G Marchesini","year":"2016","unstructured":"Marchesini G, Day C, Dufour JF, et al. EASL-EASD EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388\u2013402.","journal-title":"J Hepatol"},{"key":"3790_CR8","doi-asserted-by":"publisher","first-page":"25168","DOI":"10.3390\/ijms161025168","volume":"16","author":"MC Hernandez-Rodas","year":"2015","unstructured":"Hernandez-Rodas MC, Valenzuela R, Videla LA. Relevant aspects of nutritional and dietary interventions in Non-Alcoholic fatty liver disease. Int J Mol Sci. 2015;16:25168\u201398.","journal-title":"Int J Mol Sci"},{"key":"3790_CR9","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.3390\/ijerph16173011","volume":"16","author":"L Abenavoli","year":"2019","unstructured":"Abenavoli L, Boccuto L, Federico A, et al. Diet and Non-Alcoholic fatty liver disease: the mediterranean way. Int J Environ Res Public Health. 2019;16:3011.","journal-title":"Int J Environ Res Public Health"},{"key":"3790_CR10","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.cgh.2016.08.028","volume":"15","author":"D Kim","year":"2017","unstructured":"Kim D, Kim WR. Nonobese fatty liver disease. Clin Gastroenterol Hepatol. 2017;15:474\u201385.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3790_CR11","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/hep.20920","volume":"42","author":"E Bugianesi","year":"2005","unstructured":"Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology. 2005;42:987\u20131000.","journal-title":"Hepatology"},{"key":"3790_CR12","doi-asserted-by":"publisher","first-page":"9453","DOI":"10.3390\/nu7115475","volume":"7","author":"C Saponaro","year":"2015","unstructured":"Saponaro C, Gaggini M, Carli F, Gastaldelli A. The subtle balance be tween lipolysis and lipogenesis: a critical point in metabolic homeostasis. Nutrients. 2015;7:9453\u201374.","journal-title":"Nutrients"},{"key":"3790_CR13","first-page":"101934","volume":"4","author":"SF Tsai","year":"2023","unstructured":"Tsai SF, Yang CT, Liu WJ, Lee CL. Development and validation of an insulin resistance model for a population without diabetes mellitus and its clinical implication: a prospective cohort study. E Clini Med. 2023;4:58:101934.","journal-title":"E Clini Med"},{"issue":"1","key":"3790_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3892\/etm.2021.10996","volume":"23","author":"IM Vladu","year":"2022","unstructured":"Vladu IM, For\u021bofoiu M, Clenciu D, For\u021bofoiu MC, P\u0103dureanu R, Radu L, et al. Insulin resistance quantified by the value of HOMA-IR and cardiovascular risk in patients with type 2 diabetes. Exp Ther Med. 2022;23(1):73.","journal-title":"Exp Ther Med"},{"key":"3790_CR15","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1210\/jc.2003-030087","volume":"88","author":"GM Reaven","year":"2003","unstructured":"Reaven GM. Insulin resistance\/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. J Clin Endocrinol Metab. 2003;88:2399\u2013403.","journal-title":"J Clin Endocrinol Metab"},{"key":"3790_CR16","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.cell.2012.02.010","volume":"148","author":"FM Ashcroft","year":"2012","unstructured":"Ashcroft FM, Rorsman P. Diabetes mellitus and the \u0392 cell: the last ten years. Cell. 2012;148:1160\u201371.","journal-title":"Cell"},{"issue":"1","key":"3790_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14744\/hf.2023.2023.0045","volume":"5","author":"L Kamani","year":"2024","unstructured":"Kamani L, Rahat A, Yilmaz Y. Addressing the looming epidemic of metabolic dysfunction-associated steatotic liver disease in Pakistan: A call for action. Hepatol Forum. 2024;5(1):1\u20132. https:\/\/doi.org\/10.14744\/hf.2023.2023.0045. PMID: 38283268; PMCID: PMC10809346.","journal-title":"Hepatol Forum"},{"key":"3790_CR18","unstructured":"Turkish Diabetes Association. Insulin Resistance Workshop Report. 2017. pp. 10\u201321."},{"issue":"5","key":"3790_CR19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.14740\/gr685w","volume":"8","author":"MA Cruz","year":"2015","unstructured":"Cruz MA, Cruz JF, Macena LB, de Santana DS, Oliveira CC, Lima SO, et al. Association of the nonalcoholic hepatic steatosis and its degrees with the values of liver enzymes and homeostasis model Assessment-Insulin resistance index. Gastroenterol Res. 2015;8(5):260\u20134. pmid:27785306.","journal-title":"Gastroenterol Res"},{"key":"3790_CR20","doi-asserted-by":"crossref","unstructured":"Ilkhanipoor H, Mirrashidi FS, Dehghani SM, Moravej H. Examining the Frequency of Insulin Resistance in Children with Chronic Hepatic Disease. 2019.","DOI":"10.15226\/2374-6890\/6\/2\/001128"},{"issue":"2","key":"3790_CR21","doi-asserted-by":"publisher","first-page":"e0192663","DOI":"10.1371\/journal.pone.0192663","volume":"13","author":"J Gonzalez-Cantero","year":"2018","unstructured":"Gonzalez-Cantero J, Martin-Rodriguez JL, Gonzalez-Cantero A, Arrebola JP, Gonzalez-Calvin JL. Insulin resistance in lean and overweight non-diabetic Caucasian adults: study of its relationship with liver triglyceride content, waist circumference and BMI. PLoS ONE. 2018;13(2):e0192663.","journal-title":"PLoS ONE"},{"issue":"7","key":"3790_CR22","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1007\/s10620-015-3564-5","volume":"60","author":"M Li","year":"2015","unstructured":"Li M, Zhang S, Wu Y, Ye J, Cao X, Liu J, et al. Prevalence of insulin resistance in subjects with nonalcoholic fatty liver disease and its predictors in a Chinese population. Dig Dis Sci. 2015;60(7):2170.","journal-title":"Dig Dis Sci"},{"key":"3790_CR23","unstructured":"Swarup S, Goyal A, Grigorova Y. Metabolic Syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459248\/"},{"issue":"4","key":"3790_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1620\/tjem.212.349","volume":"212","author":"JD Lin","year":"2007","unstructured":"Lin JD, Wan H-L, Li J-C, Wu C-Z, Kuo S-W, Hsieh C-H, et al. Impaired glucose tolerance and impaired fasting glucose share similar underlying pathophysiologies. Tohoku J Exp Med. 2007;212(4):349\u201357.","journal-title":"Tohoku J Exp Med"},{"issue":"7","key":"3790_CR25","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia"},{"issue":"10","key":"3790_CR26","doi-asserted-by":"publisher","first-page":"300060523120446","DOI":"10.1177\/03000605231204462","volume":"51","author":"P Zeng","year":"2023","unstructured":"Zeng P, Cai X, Yu X, Huang L, Chen X. HOMA-IR is an effective biomarker of non-alcoholic fatty liver disease in non-diabetic population. J Int Med Res. 2023;51(10):3000605231204462.","journal-title":"J Int Med Res"},{"key":"3790_CR27","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","volume":"67","author":"JG Fan","year":"2017","unstructured":"Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol. 2017;67:862\u201373.","journal-title":"J Hepatol"},{"key":"3790_CR28","doi-asserted-by":"crossref","unstructured":"Neergaard JS, Dragsb\u00e6k K, Christiansen C. Metabolic syndrome, insulin resistance, and cognitive dysfunction: does your metabolic profile affect your brain? Diabetes. 2017;66:1957\u201363.","DOI":"10.2337\/db16-1444"},{"key":"3790_CR29","doi-asserted-by":"publisher","unstructured":"Motamed B, Kohansal Vajargah M, Kalantari S, Shafaghi A. HOMA-IR index in non-diabetic patient, a reliable method for early diagnosis of liver steatosis. Casp J Intern Med. 2022 Summer;13(3):519\u201326. https:\/\/doi.org\/10.22088\/cjim.13.3.519. PMID: 35974947; PMCID: PMC9348208.","DOI":"10.22088\/cjim.13.3.519"},{"key":"3790_CR30","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1515\/cclm-2021-0643","volume":"59","author":"B Matli","year":"2021","unstructured":"Matli B, Schulz A, Koeck T. Distribution of HOMA-IR in a population based cohort and proposal for reference intervals. Clin Chem Lab Med. 2021;59:1844\u201351.","journal-title":"Clin Chem Lab Med"},{"issue":"8","key":"3790_CR31","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1111\/jgh.14595","volume":"34","author":"H Fujii","year":"2019","unstructured":"Fujii H, Imajo K, Yoneda M, Nakahara T, Hyogo H, Takahashi H, et al. HOMA-IR: an independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2019;34(8):1390\u201395.","journal-title":"J Gastroenterol Hepatol"},{"key":"3790_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1365-2796.2010.02325.x","volume":"269","author":"GM Reaven","year":"2011","unstructured":"Reaven GM. The metabolic syndrome: time to get off the merry-go-round? J Intern Med. 2011;269:127\u201336.","journal-title":"J Intern Med"},{"issue":"5","key":"3790_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1055\/a-0603-7899","volume":"50","author":"X Sheng","year":"2018","unstructured":"Sheng X, Che H, Ji Q, Yang F, Lv J, Wang Y, et al. The relationship between liver enzymes and insulin resistance in type 2 diabetes patients with nonalcoholic fatty liver disease. Horm Metab Res. 2018;50(5):397\u2013402.","journal-title":"Horm Metab Res"},{"issue":"10","key":"3790_CR34","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.nutres.2013.07.019","volume":"33","author":"B Gray","year":"2013","unstructured":"Gray B, Muhlhausler BS, Davies PS, Vitetta L. Liver enzymes but not free fatty acid levels predict markers of insulin sensitivity in overweight and obese, nondiabetic adults. Nutr Res. 2013;33(10):781\u20138.","journal-title":"Nutr Res"},{"key":"3790_CR35","doi-asserted-by":"crossref","unstructured":"Li W, Homer K, Hull S, Boomla K, Robson J, Alazawi W. Obesity predicts liver function testing and abnormal liver results. Obesity (Silver Spring). 2019.","DOI":"10.1002\/oby.22669"},{"issue":"4","key":"3790_CR36","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/MEG.0000000000000811","volume":"29","author":"LE Simental-Mendia","year":"2017","unstructured":"Simental-Mendia LE, Rodriguez-Moran M, Gomez-Diaz R, Wacher NH, Rodriguez-Hernandez H, Guerrero-Romero F. Insulin resistance is associated with elevated transaminases and low aspartate aminotransferase\/alanine aminotransferase ratio in young adults with normal weight. Eur J Gastroenterol Hepatol. 2017;29(4):435\u201340.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"9","key":"3790_CR37","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S2221-1691(12)60213-5","volume":"2","author":"ME Ghamar-Chehreh","year":"2012","unstructured":"Ghamar-Chehreh ME, Amini M, Khedmat H, Moayed Alavian S, Daraei F, Mohtashami R, et al. Elevated Alanine aminotransferase activity is not associated with dyslipidemias, but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver disease. Asian Pac J Trop Biomed. 2012;2(9):702\u20136.","journal-title":"Asian Pac J Trop Biomed"},{"issue":"1 Suppl 1","key":"3790_CR38","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.dsx.2015.09.005","volume":"10","author":"IA Hossain","year":"2016","unstructured":"Hossain IA, Rahman Shah MM, Rahman MK, Ali L. Gamma Glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: association of GGT and HOMA-IR with NAFLD. Diabetes Metab Syndr. 2016;10(1 Suppl 1):S25\u20139.","journal-title":"Diabetes Metab Syndr"},{"issue":"5","key":"3790_CR39","doi-asserted-by":"publisher","first-page":"709","DOI":"10.2217\/bmm.13.71","volume":"7","author":"R Bradley","year":"2013","unstructured":"Bradley R, Fitzpatrick AL, Jenny NS, Lee DH, Jacobs DR Jr. Associations between total serum GGT activity and metabolic risk: MESA. Biomark Med. 2013;7(5):709\u201321.","journal-title":"Biomark Med"},{"issue":"17","key":"3790_CR40","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1056\/NEJM200004273421707","volume":"342","author":"DS Pratt","year":"2000","unstructured":"Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med. 2000;342(17):1266\u201371.","journal-title":"N Engl J Med"},{"issue":"2","key":"3790_CR41","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1097\/MCG.0000000000000946","volume":"53","author":"CM Parrinello","year":"2019","unstructured":"Parrinello CM, Rudolph BJ, Lazo M, Gallo LC, Thyagarajan B, Cotler SJ, et al. Associations of insulin resistance and glycemia with liver enzymes in Hispanic\/Latino youths: results from the Hispanic community children\u2019s health study\/study of Latino youth (SOL youth). J Clin Gastroenterol. 2019;53(2):e46\u201353.","journal-title":"J Clin Gastroenterol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03790-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03790-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03790-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:49:20Z","timestamp":1744717760000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03790-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3790"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03790-6","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"1 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was taken before the start of the study from Liaquat National Hospital Ethics committee, where this study was undertaken. This study was carried out in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants gave informed consent before enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared no conflict of interest and all authors have studied and approved the final manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This declaration acknowledges that this paper adheres to the principle for transparent reporting and scientific rigour of research as stated in the guidelines and as recommended by funding agencies, publishers and other organizations engaged with supporting research.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Transparency and scientific rigour"}}],"article-number":"259"}}